A
Andreas Herbst
Researcher at Ludwig Maximilian University of Munich
Publications - 36
Citations - 2399
Andreas Herbst is an academic researcher from Ludwig Maximilian University of Munich. The author has contributed to research in topics: Colorectal cancer & Wnt signaling pathway. The author has an hindex of 19, co-authored 35 publications receiving 1995 citations. Previous affiliations of Andreas Herbst include German Cancer Research Center & University of Kiel.
Papers
More filters
Journal ArticleDOI
Circular non-coding RNA ANRIL modulates ribosomal RNA maturation and atherosclerosis in humans.
Lesca M. Holdt,Anika Stahringer,Kristina Sass,Garwin Pichler,Nils A. Kulak,Wolfgang Wilfert,Alexander Kohlmaier,Andreas Herbst,Bernd H. Northoff,Alexandros Nicolaou,Gabor Gäbel,Frank Beutner,Markus Scholz,Joachim Thiery,Kiran Musunuru,Knut Krohn,Matthias Mann,Daniel Teupser,Daniel Teupser +18 more
TL;DR: These findings identify circANRIL as a prototype of a circRNA regulating ribosome biogenesis and conferring atheroprotection, thereby showing that circularization of long non-coding RNAs may alter RNA function and protect from human disease.
Journal ArticleDOI
Comprehensive analysis of β-catenin target genes in colorectal carcinoma cell lines with deregulated Wnt/β-catenin signaling
Andreas Herbst,Vindi Jurinovic,Stefan Krebs,Susanne E. Thieme,Helmut Blum,Burkhard Göke,Frank T. Kolligs +6 more
TL;DR: DLD1 and SW480 colon carcinoma cell lines are suitable model systems to study Wnt/β- catenin signaling and associated colorectal carcinogenesis and the confirmed and the newly identified potential β-catenin target genes are useful starting points for further studies.
Journal ArticleDOI
Methylation of serum DNA is an independent prognostic marker in colorectal cancer.
Maike Wallner,Andreas Herbst,Andrea Behrens,Alexander Crispin,Petra Stieber,Burkhard Göke,Rolf Lamerz,Frank T. Kolligs +7 more
TL;DR: In this article, the methylation status of specific genes in the serum of patients with colorectal cancer has the potential to become a pretherapeutic predictor of outcome.
Journal Article
Methylation of serum DNA is an independent prognostic marker in colorectal cancer. Commentary
Maike Wallner,Andreas Herbst,Andrea Behrens,Alexander Crispin,Petra Stieber,Burkhard Göke,Rolf Lamerz,Frank T. Kolligs,Martin Widschwendter,Usha Menon +9 more
TL;DR: Data show that the methylation status of specific genes in the serum of patients with colorectal cancer has the potential to become a pretherapeutic predictor of outcome.
Journal ArticleDOI
Methylation of NEUROG1 in Serum Is a Sensitive Marker for the Detection of Early Colorectal Cancer
Andreas Herbst,Konstanze Rahmig,Petra Stieber,Alexander Philipp,Andreas Jung,Andrea Ofner,Alexander Crispin,Jens Neumann,Rolf Lamerz,Frank T. Kolligs +9 more
TL;DR: Methylation of the NEUROG1 gene is frequently found in sera of patients with colorectal cancers independent of tumor stage, and the quantitative detection of NEurOG1 DNA methylation in serum is a suitable approach for the non-invasive screening for asymptomatic colorec cancer.